Keyword: Robert Califf

Regulators stand accused of waving through drugs on the basis of slight data and then failing to ensure postapproval trials validate the decision.

Francis Collins remains NIH chief, but billions of dollars in cuts could be on the way.

Robert Califf, the FDA commissioner under President Barack Obama, is in talks with Verily for a leadership position.

As expected, Scott Gottlieb, M.D., has been confirmed as the new head of the FDA, about four months after his Obama-picked predecessor Robert Califf stepped down.

Former FDA chief Califf leads a PCORI-backed research foundation, ex-Shire exec Shepard jumped to Eisai's oncology business, and Forty Seven hired former Sandoz exec McCamish as new CEO.

Former FDA commissioner Robert Califf, who was not asked back into his role by President Donald Trump, has become the new chair of the newly formed People-Centered Research Foundation (PCRF).

President Donald Trump has chosen Scott Gottlieb to run the FDA, setting the stage for faster approvals, greater regulatory transparency.

The belief that the FDA is to undergo a major shift in thinking was given further credence as another curveball was thrown into the mix.

It seems that president elect Donald Trump wants an investor as the next FDA commissioner, as Dr. Scott Gottlieb, a partner at one of the world's largest venture capital funds, is also now rumored by Reuters to be on his short-list for the top job.

A litmus test of President-elect Donald Trump's plans for the FDA will come when the agency's commissioner hands in his resignation letter in the coming weeks.